|
|
Articles related to Pathfinder Therapeutics
Centerstone of America seeks commercial prowess to get technologies to market. Posted on: October 10, 2014 By: Milt Capps updated Nov. 2, 2015, 1939hrs [updated] Stefansic and Hogin among those departing, with interest in private-sector jobs. Posted on: October 3, 2014 By: Milt Capps edits 10:07 a.m. Oct. 4, 2014 After a decade widening Nashville's lifesciences entrepreneurship, a strategic move. TTDC now seems to be fully staffed to further pro-venture programs By: By Milt Capps updated May 26, 2012 There are some new faces among the 'usual suspects' applying at INCITE Fund By: By Milt Capps updated Dec. 5, 2013 [EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders By: By VNC Staff updated March 6, 2012 8:36 a.m. The latest CEO appointment at the helm of Pathfinder has a med-devices background. Posted on: February 9, 2012 By: By Milt Capps updated 10:35 a.m. Students have decided they can't wait on the rest of the world to create the great jobs they want Posted on: October 3, 2011 ACG plans to open five new city chapters soon; for now, its Memphis outpost is semi-shuttered Posted on: September 20, 2011 By: By Milt Capps Updated 2:08 p.m. Executive transitions, capital raises, alliances and innovations. Posted on: August 9, 2011 Reports from the front lines of entrepreneurship keep trickling in Posted on: April 27, 2011 ' Overhaul and investment ' could lead to accelerated enterprise development from VU research and development Posted on: March 14, 2011 By: By Milt Capps Updated 7:28 p.m. Airing of issues simmering beneath TNInvestco's surface has prompted a reprise of comments pro and con the program Posted on: March 26, 2010 By: By Milt Capps Last updated 10:04 p.m. It may be only the tip of the Engineering iceberg at Vanderbilt, but here's a sample of the fruits of education and research Posted on: February 8, 2010 By: By Milt Capps Last updated 9:52 a.m. Feb. 9, 2010 Quiet figure behind the scenes of a Vanderbilt-spawned startup steps forward with observations and appreciation Posted on: September 17, 2009 By: By Milt Capps Last Updated 4:56 p.m. Christopher Rand's presentation underscores gaps in the capital continuum, but suggests a target-rich environment for seed-stage investors By: By Milt Capps Last Updated 5:35 P.M. With $17.2 billion soon under the scalpel, startup feels it has a better mousetrap for improving quality and financial returns Posted on: March 11, 2009 By: By Milt Capps UPDATED 12:44 p.m. UPDATED 12:44 p.m.Nationwide search lands med-devices veteran for persistent Vanderbilt spin-out Posted on: January 28, 2009 Two very different enterprises - Uloop and Pathfinder Therapeutics - are on the money trail, once again Posted on: November 23, 2008 Hundreds of discoveries and patents on-hand, Vanderbilt expands its efforts to commercialize intellectual property Posted on: October 30, 2008 After a long sojourn in the VC desert, a VU spinout finds it A-round lead in North Carolina Posted on: September 23, 2008 Venture continues to scout capital, relying on federal grants to stay alive and hoping for a break Making scientific discoveries that can survive the punishing path toward the market is hard enough. Now that the FDA has approved marketing that could save liver-cancer patients' lives, Pathfinder Therapeutics hopes local investors and the State of Tennessee can lend a hand. But, they're not holding their breath.
There are still 21 active portfolio companies over which Chris McKinney says grace. |
|
|
